1. What specific clinical and laboratory findings in Maria's case strongly indicate a diagnosis of methicillin-resistant Staphylococcus aureus (MRSA) cellulitis, and how do these differentiate from other types of cellulitis?
2. Considering the diagnosis of MRSA cellulitis, what differential diagnoses should be considered based on her symptoms and what additional tests would help clarify these possibilities?
3. What potential complications could arise from MRSA cellulitis, and how can they be monitored and managed effectively in Maria's treatment plan?
4. How certain can we be of the MRSA diagnosis based on the available data, and what further diagnostic evaluations could increase the confidence in this diagnosis?
5. In managing Maria's MRSA infection, how might laboratory findings guide adjustments in treatment choices, and what role does ongoing monitoring of these parameters play in preventing complications?